Yelena Tropsha

CIK 1744954 · View on SEC EDGAR ↗

Insider

First SEC filing: June 27, 2018 · Latest: June 27, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 10, 2020 STIM F 898 $1.98 $1,778 65,987 Direct -1.34% Disposed 56.1% (price as of 2026-08-21)
March 5, 2020 STIM A 38,750 66,885 Direct +137.73% Acquired (price as of 2026-08-21)
Jan. 15, 2020 STIM A 19,000 28,135 Direct +207.99% Acquired (price as of 2026-08-21)
March 8, 2019 STIM A 16,077 16,077 Direct Acquired (price as of 2026-08-21)
March 8, 2019 STIM A 9,135 9,135 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 8, 2019 STIM Employee Stock Option (right to buy) Common Stock (16,077) $16.42 March 8, 2029 16,077 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 27, 2018 STIM Employee Stock Option (Right to Buy)→ Common Stock (84,010) 84,010 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

STIM

Vice President, Commercial Access Medical Operations(5)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2018

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.